DK0580685T3 - Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift - Google Patents

Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift

Info

Publication number: DK0580685T3
Authority: DK; Denmark
Prior art keywords: unit containing; packaging unit; bolus administration; plasminogen activators; pharmaceutical packaging
Prior art date: 1991-04-16

Application number

DK92908637.9T

Other languages

English (en)

Inventor

Ulrich Martin

Reinhard Koenig

Original Assignee

Boehringer Mannheim Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-16

Filing date

1992-04-15

Publication date

1996-03-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25902885&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0580685(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-07-18 Priority claimed from DE19914123845 external-priority patent/DE4123845A1/de

1992-04-15 Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh

1996-03-04 Application granted granted Critical

1996-03-04 Publication of DK0580685T3 publication Critical patent/DK0580685T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK92908637.9T 1991-04-16 1992-04-15 Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift DK0580685T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4112398		1991-04-16
DE19914123845 DE4123845A1 (de)	1991-07-18	1991-07-18	Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe

Publications (1)

Publication Number	Publication Date
DK0580685T3 true DK0580685T3 (da)	1996-03-04

Family

ID=25902885

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92908637.9T DK0580685T3 (da)	1991-04-16	1992-04-15	Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift

Country Status (11)

Country	Link
US (3)	US5500411A (da)
EP (2)	EP0709096A2 (da)
JP (1)	JPH06506459A (da)
AT (1)	ATE132373T1 (da)
CA (1)	CA2107476C (da)
DE (1)	DE59204945D1 (da)
DK (1)	DK0580685T3 (da)
ES (1)	ES2082465T3 (da)
GR (1)	GR3018740T3 (da)
HK (1)	HK117096A (da)
WO (1)	WO1992018157A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0580685T3 (da) *	1991-04-16	1996-03-04	Boehringer Mannheim Gmbh	Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift
US5510330A (en) †	1994-03-25	1996-04-23	Boehringer Mannheim Gmbh	Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
WO1998006426A1 (en) *	1996-08-14	1998-02-19	Gram Joergen Brodersen	Use of a plasminogen activator for the treatment of pulmonary disorders
WO2002052006A1 (fr) *	2000-12-26	2002-07-04	Genox Research, Inc.	Methode permettant d'examiner une maladie allergique
DE10153601A1 (de) *	2001-11-02	2003-05-22	Paion Gmbh	DSPA zur Behandlung von Schlaganfall
US7084118B2 (en) *	2002-02-22	2006-08-01	Genentech, Inc.	Combination treatment with t-PA variant and low molecular weight heparin
US20070142272A1 (en) *	2003-01-24	2007-06-21	Zlokovic Berislav V	Neuroprotective activity of activated protein c independent of its anticoagulant activity
US20100260669A1 (en) *	2004-05-13	2010-10-14	Anthony Joonkyoo Yun	Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
CA2574598A1 (en) *	2004-07-23	2006-02-09	The University Of Rochester	Activated protein c inhibits undesirable effects of plasminogen activator in the brain
US8309063B2 (en) *	2005-06-10	2012-11-13	Amcol International Corporation	Stable sunscreen compositions containing zinc oxide
AR068914A1 (es) *	2007-10-18	2009-12-16	Paion Deutschland Gmbh	Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia
EP4592322A1 (en) *	2022-09-23	2025-07-30	Chuang, Woei-jer	Fusion protein targeting intergrin alpha(iib)beta3 and containing tissue plasminogen activator or variant thereof and use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5234686A (en) *	1985-04-03	1993-08-10	Beecham Group P.L.C.	Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
GB8508717D0 (en) *	1985-04-03	1985-05-09	Beecham Group Plc	Composition
ZW14486A1 (en) *	1985-07-29	1986-10-22	Smithkline Beckman Corp	Pharmaceutical dosage unit
WO1989000197A1 (en) *	1987-06-30	1989-01-12	Genentech, Inc.	Improved processes for the treatment of vascular disease
US4935237A (en) *	1988-03-21	1990-06-19	Genentech, Inc.	Processes for the preparation of t-PA mutants
US5084274A (en) *	1987-11-17	1992-01-28	Scripps Clinic And Research Foundation	Inhibition of arterial thrombotic occlusion or thromboembolism
US5342616A (en) *	1988-06-20	1994-08-30	The Wellcome Foundation Limited	Method of administering tissue plasminogen activator
GB8814604D0 (en) *	1988-06-20	1988-07-27	Wellcome Found	Medicaments
FI100403B (fi) *	1988-07-20	1997-11-28	Schering Ag	Menetelmä glykosyloitujen tai glykosyloimattomien vampyyrilepakon sylj en plasminogeeniaktivaattoreiden valmistamiseksi
US4980165A (en) *	1989-01-27	1990-12-25	Genetics Institute, Inc.	Pharmaceutical formulations of plasminogen activator proteins
DE3903581A1 (de) *	1989-02-07	1990-08-16	Boehringer Mannheim Gmbh	Gewebs-plasminogenaktivator-derivat
DE3942141A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	K2p pro-stabilisierung
DE3942143A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	T-pa pro stabilisierung
US5366730A (en) *	1989-12-20	1994-11-22	Boehringer Mannheim Gmbh	Stabilized compositions having human tissue type plasminogen activator enzymatic activity
US5242688A (en) *	1990-12-24	1993-09-07	Eli Lilly And Company	Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
DK0580685T3 (da) *	1991-04-16	1996-03-04	Boehringer Mannheim Gmbh	Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift

1992
- 1992-04-15 DK DK92908637.9T patent/DK0580685T3/da active
- 1992-04-15 CA CA002107476A patent/CA2107476C/en not_active Expired - Lifetime
- 1992-04-15 JP JP4507994A patent/JPH06506459A/ja active Pending
- 1992-04-15 AT AT92908637T patent/ATE132373T1/de not_active IP Right Cessation
- 1992-04-15 DE DE59204945T patent/DE59204945D1/de not_active Revoked
- 1992-04-15 US US08/137,116 patent/US5500411A/en not_active Expired - Lifetime
- 1992-04-15 WO PCT/EP1992/000851 patent/WO1992018157A1/de not_active Ceased
- 1992-04-15 ES ES92908637T patent/ES2082465T3/es not_active Expired - Lifetime
- 1992-04-15 EP EP95106049A patent/EP0709096A2/de not_active Withdrawn
- 1992-04-15 EP EP92908637A patent/EP0580685B1/de not_active Revoked
1994
- 1994-03-25 US US08/217,616 patent/US5690931A/en not_active Expired - Lifetime
1996
- 1996-01-19 GR GR960400126T patent/GR3018740T3/el unknown
- 1996-07-04 HK HK117096A patent/HK117096A/xx not_active IP Right Cessation
1997
- 1997-02-03 US US08/794,528 patent/US6235279B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0580685B1 (de)	1996-01-03
US5690931A (en)	1997-11-25
CA2107476A1 (en)	1992-10-17
HK117096A (en)	1996-07-12
US6235279B1 (en)	2001-05-22
ATE132373T1 (de)	1996-01-15
GR3018740T3 (en)	1996-04-30
JPH06506459A (ja)	1994-07-21
ES2082465T3 (es)	1996-03-16
CA2107476C (en)	2007-12-18
EP0709096A3 (da)	1996-05-08
EP0709096A2 (de)	1996-05-01
EP0580685A1 (de)	1994-02-02
WO1992018157A1 (de)	1992-10-29
DE59204945D1 (de)	1996-02-15
US5500411A (en)	1996-03-19

Publication	Publication Date	Title
DK0580685T3 (da)	1996-03-04	Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift
DE68913132D1 (de)	1994-03-24	Hirudin und Aktivator des Plasminogens enthaltende pharmazeutische wirksame Verbindung.
DE59209967D1 (de)	2002-10-31	Arzneimittel enthaltend aktiviertes Protein C
NO20061094L (no)	1995-07-13	Antistoff samt anvendelse derav til fremstilling av medikamenter til behandling av B-celle-lymfom
EP0850648A3 (en)	2004-03-31	Combination of thrombolytically active proteins and anticoagulants and uses thereof
DE3669103D1 (de)	1990-04-05	Ibuprofen enthaltendes arzneimittel.
ATE177645T1 (de)	1999-04-15	Stabilisierte pharmazeutische formulierung, die wachstumshormon und asparagin enthält
EP0233013A3 (en)	1987-10-14	Modified enzyme
FR2629699B1 (fr)	1991-09-06	Dispositif de presentation de marchandises et produits divers, notamment dans des magasins de vente
DE59811768D1 (de)	2004-09-09	Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
DE69008513D1 (de)	1994-06-01	Pharmazeutische formulierung von plasminogenaktivatorproteinen.
ES2175006T3 (es)	2002-11-16	N-(pirimidinil)-benzosulfonamidas como medicamentos.
DK428089A (da)	1990-03-01	Anvendelse af plasminogen-aktivator-inhibitor (pai-2) til immunsuppression
ATE71535T1 (de)	1992-02-15	Pharmazeutische zubereitungen.
FI102970B1 (fi)	1999-03-31	Uusi ihmiskudostyyppinen plasminogeeni aktivaattori muunnelma
DE68901114D1 (de)	1992-05-07	Tpa enthaltende arzneimittel.
DK0402208T3 (da)	1994-02-14	Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet
DK0610655T3 (da)	1996-07-08	Lægemidler med et indhold af dexpanthenol til topisk anvendelse
DK192487D0 (da)	1987-04-14	Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
IE880198L (en)	1988-07-28	Plasminogen activator.